Impact Factor 3.517 | CiteScore 3.60
More on impact ›
Submit your manuscript
Scope
Cancer Genetics welcomes manuscripts contributing to the understanding of the impact of genetic aberrations in carcinogenesis, as well as in the progression and outcomes of cancer. (Basic, translational and clinical research is welcome, with genetic, genomic and transcriptomic studies being considered for the section).
Manuscripts consisting solely of bioinformatic research, as well as focused on proteomic and metabolomic investigation, are regrettably not suitable for this specialty.
Scope
The acquisition of somatic genetic aberrations is central to the development of cancer, along with the constitutional genetic background of each patient in their cancer risk and response to therapy. Current technologies provide ever more powerful approaches to study and validate these highly complex phenomena. The Cancer Genetics specialty section will facilitate the publication of high-quality original research and review articles pertaining to the genetic, genomic and molecular aspects of cancer, and technical advances that facilitate progress in this field.
Focused primarily on molecular genetic aberrations driving malignant processes in human cancers, the scope of submissions will include investigations in the following areas:
- Basic and translational studies reporting large-scale genomic and transcriptomic data (e.g. gene expression, copy number, sequencing, DNA polymorphism, and epigenetics) and studies employing classical and molecular cytogenetic techniques.
- Advances in bioinformatics, statistical, and systems approaches to enable novel biological and clinical interpretation of large-scale datasets.
- Studies demonstrating a correlation of genetic changes with pathology and clinical presentation.
- Genetics, genomics and RNA-based biomarker development.
- Whole genome studies and focused studies of individual genes contributing to cancer molecular pathways.
- New rationales for bringing molecular genetic findings to the clinical oncology space.
Submissions not in scope for this specialty include:
- Those consisting solely of bioinformatic investigation of publicly available genomic / transcriptomic data without experimental or in situ validation to support conclusions.
- Those focused on proteomic and metabolomic investigation.
Indexed in: PubMed, PubMed Central, Scopus, Google Scholar, DOAJ, CrossRef, Chemical Abstracts Service (CAS), EMBASE, AGRICOLA, Semantic Scholar, Ulrich's Periodicals Directory, Science Citation Index Expanded, BIOSIS Citation Index, Biological Abstracts, CLOCKSS, EBSCO, OpenAIRE, Zetoc, Mastermind
PMCID: all published articles receive a PMCID
Cancer Genetics welcomes submissions of the following article types: Clinical Trial, Correction, Editorial, Hypothesis and Theory, Methods, Mini Review, Opinion, Original Research, Perspective, Review, Specialty Grand Challenge, Systematic Review and Technology and Code.
All manuscripts must be submitted directly to the section Cancer Genetics, where they are peer-reviewed by the Associate and Review Editors of the specialty section.
Frontiers Editorial Office
Avenue du Tribunal Fédéral 34
CH – 1005 Lausanne
Switzerland
Tel +41(0)21 510 17 40
Fax +41 (0)21 510 17 01
Frontiers Support
Tel +41(0)21 510 17 10
Fax +41 (0)21 510 17 01
support@frontiersin.org
There are no results to display.
Click on any of the keywords to find further editors related to it.
- Article(s) found
- Latest
- Most viewed
This section has no articles.
There are no articles to display. Please try changing the filters.
- Research Topic(s) found
- Latest
- Most viewed
Contact Editorial Office
Avenue du Tribunal Fédéral 34
CH – 1005 Lausanne
Switzerland
Tel +41(0)21 510 17 40
Fax +41 (0)21 510 17 01
For all queries regarding manuscripts in Review and potential conflicts of interest, please contact genetics.editorial.office@frontiersin.org
For queries regarding Research Topics, Editorial Board applications, and journal development, please contact genetics@frontiersin.org
Tel +41(0)21 510 17 10
Fax +41 (0)21 510 17 01
For technical issues, please visit our Frontiers Help Center, or contact our IT HelpDesk team at support@frontiersin.org